- Record: found
- Abstract: not found
- Article: not found
Pazopanib as Second-line Antiangiogenic Treatment in Metastatic Renal Cell Carcinoma After Tyrosine Kinase Inhibitor (TKI) Failure: A Phase 2 Trial Exploring Immune-related Biomarkers for Testing in the Post-immunotherapy/TKI Era
Joaquim Bellmunt ,
Emilio Esteban ,
Xavier García del Muro ,
Juan Manuel Sepúlveda ,
Pablo Maroto ,
Enrique Gallardo ,
Aranzazu González del Alba ,
Olatz Etxaniz ,
Marta Guix ,
Jose Luis González Larriba ,
Jose A. Arranz ,
Miriam Redrado ,
Alfonso Calvo
August 2019
August 2019
Read this article at
ScienceOpenPublisher
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.